* Receives marketing authorisation for nucala (mepolizumab) in Japan
The post BRIEF-Japan approves GlaxoSmithkline’s asthma drug Nucala appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Receives marketing authorisation for nucala (mepolizumab) in Japan
The post BRIEF-Japan approves GlaxoSmithkline’s asthma drug Nucala appeared first on NASDAQ.